ClearPoint Neuro Inc (CLPT) is a healthcare technology company that specializes in providing navigation and delivery solutions for brain procedures. The company's innovative technology enables neurosurgeons to perform more precise and efficient procedures, ultimately improving patient outcomes. As an investor, it is important to analyze the technical indicators of CLPT stock to make informed decisions.

One of the key technical indicators to consider is the Relative Strength Index (RSI). The RSI measures the speed and change of price movements and helps identify overbought or oversold conditions. A high RSI value above 70 indicates an overbought condition, while a low RSI value below 30 indicates an oversold condition. Monitoring the RSI can help determine potential price reversals or continuations.

ClearPoint Neuro  (CLPT) Technical Analysis

ClearPoint Neuro Inc (CLPT) stock technical analysis indicators including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Discover key signals for ClearPoint Neuro Inc (CLPT) stock using technical analysis.

ClearPoint Neuro Inc (CLPT) Technical Analysis: Indicators, RSI, ADX, MACD, ROC, STOCHRSI, WILLR

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	42.45	Neutral	-
auto_graphMACD	-0.21	Neutral	-21.2%
auto_graphCCI	-47.04	Neutral	58.6%
auto_graphADX	98.20	Neutral	-28.8%
auto_graphATR	3.26	Buy	-
auto_graphWILLR	-94.38	Buy	34.2%
auto_graphROC	-39.75	Neutral	-88.3%
auto_graphSTOCHRSI	13.05	Buy	25671.7%

Buy	3	-62.50%
Hold	5	-37.50%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

ClearPoint Neuro (CLPT) Technical Analysis

Keep an eye on ClearPoint Neuro

Frequently Asked Questions

What are the technical signals for ClearPoint Neuro (CLPT) stock based on the last 30 days?

Take Your Investments to a Whole New Level